KCNQ2 Gene Early Infantile Epileptic Encephalopathy Type 7 NGS Genetic DNA Test
Introduction to the Test
The KCNQ2 Gene Early Infantile Epileptic Encephalopathy Type 7 NGS Genetic DNA Test is a groundbreaking diagnostic tool designed to identify mutations in the KCNQ2 gene, which are known to cause early infantile epileptic encephalopathy (EIEE). This condition is characterized by frequent seizures and developmental delays in infants. Understanding the genetic basis of EIEE is crucial for effective management and treatment, making this test an important resource for neurologists and families.
What the Test Measures
This test employs Next Generation Sequencing (NGS) technology to detect specific mutations in the KCNQ2 gene. By analyzing the DNA, healthcare providers can ascertain whether a child has inherited a genetic predisposition to EIEE, allowing for better-informed decisions regarding treatment and care.
Who Should Consider This Test?
Parents of infants exhibiting symptoms such as:
- Frequent seizures
- Developmental delays
- Abnormal muscle tone
- Family history of epilepsy or neurological disorders
should consider this test. Additionally, children with unexplained neurological symptoms may benefit from genetic testing to rule out KCNQ2-related conditions.
Benefits of Taking the Test
- Early and accurate diagnosis of KCNQ2-related EIEE
- Informed treatment options based on genetic findings
- Enhanced understanding of the disorder for families
- Potential for prenatal testing and family planning
Understanding Your Results
Results from the KCNQ2 Gene test can provide valuable insights into the genetic factors affecting your child’s health. A genetic counseling session is recommended to help interpret the results and discuss potential implications. The results will indicate whether a mutation is present and guide further management strategies.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400000 NGN |
| Regular Price | 560000 NGN |
Book the Test
To book the KCNQ2 Gene Early Infantile Epileptic Encephalopathy Type 7 NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and provide any additional information you may need.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected with KCNQ2 Gene Early Infantile Epileptic Encephalopathy Type 7.
Specialty: Neurology
Department: Genetics
Method: NGS Technology
Disease Type: Neurological Disorders
